Gi Insights

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Adam S. Cheifetz, MD Therapeutic drug monitoring has emerged as an important tool to optimize therapy for patients with inflammatory bowel disease (IBD). To help us learn more about this tool, Dr. Peter Buch is joined by Dr. Adam Cheifetz of Beth Israel Deaconess Medical Center and Professor of Medicine at Harvard Medical School.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Asma Khapra, MD Over the last few years, we've only started to gain an understanding of how gender affects our approach to GI illnesses. And since a greater awareness of these differences will help us become better clinicians, Dr. Peter Buch speaks with Dr. Asma Khapra about how we can optimize our approach to managing common GI illnesses in our female patients.

Host: Neilanjan Nandi, MD Guest: Peter D. Higgins, MDm PhD What's on the horizon for the management of inflammatory bowel disease? To share some of the latest clinical trial updates, Dr. Neil Nandi is joined by Dr. Peter Higgins from the University of Michigan to explore some of the latest developments in early detection tools and treatment strategies for patients with IBD.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Rashid N. Lui, MD Immune checkpoint inhibitors have evolved the treatment landscape for cancer, but we need to consider the GI side effects. To do so, Dr. Peter Buch is joined by Dr. Rashid N. Lui to assess the GI impacts of ICIs and how to manage them.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Michael L. Weinstein, MD As clinicians, providing the best quality of care is paramount. But when it comes to procedure-intensive specialties, medical malpractice is a notable concern. So what do we need to know about the common malpractice claims in the GI field, and how can we mitigate the risk of those claims? To find out, Dr. Peter Buch is joined by Dr. Michael Weinstein, President and CEO of Capital Digestive Care.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Alexander Perelman, D.O. Proton pump inhibitors (PPIs) are among the most frequently prescribed medications in the world, but in many instances, they may be unnecessary. So how might this impact our patients’ health, and how can we identify those patients who should be prescribed PPIs? Dr. Peter Buch is joined by Dr. Alexander Perelman to talk about the overuse of PPIs.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Hetal A. Karsan, MD, FACG, FAASLD, FASGE, FACP Primary biliary cholangitis, which was formerly known as primary biliary cirrhosis, is a chronic disease that progresses over time. Fortunately, much progress has been made in that many patients are being diagnosed and treated much earlier than before. But what exactly has changed when it comes to our detection and treatment of this disease? Dr. Peter Buch is joined by Dr. Hetal Karsan, Adjunct Professor of Medicine in the Division of Digestive Diseases at Emory University School of Medicine, to discuss key updates in primary biliary cholangitis care.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Lea Ann Chen, MD As clinicians, we know that adherence to treatment regimens is associated with improved outcomes in our patients with inflammatory bowel disease (IBD). However, many factors can contribute to a patient's nonadherence, and understanding what those factors are, especially in underserved patient populations, is an important category of care that we need to keep in mind. Tune in to hear Dr. Peter Buch speak with Dr. Lea Ann Chen about how we can manage IBD in underserved patient populations.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Erick Argueta, MD Since only 70 percent of initial eradication attempts of Helicobacter pylori are successful, it’s important for us to understand the factors that might be contributing to this startling statistic. That’s why Dr. Peter Buch speaks with Dr. Erick Argueta about why Helicobacter pylori can be difficult to eradicate and how we can best treat this infection.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Benjamin L. Cohen, MD Inflammatory bowel disease (IBD) among the elderly is common, and when compared to IBD in younger patients, it’s characterized by a different disease course and has an increased risk of mortality. So how can we achieve better outcomes for our elderly patients? Dr. Peter Buch is joined by Dr. Benjamin Cohen, Co-Section Head and Clinical Director for Inflammatory Bowel Disease at the Cleveland Clinic, to discuss evaluation and treatment strategies for our elderly patients with IBD.

Host: Neilanjan Nandi, MD Guest: Monica Schwartzman, MD, MS It's estimated that 50 percent of patients with IBD experience arthralgia, with the most common form being peripheral arthritis. What screening strategies are available to help us identify those patients with peripheral discomforts? Tune in to hear multidisciplinary perspectives on peripheral arthritis in IBD from gastroenterologist Dr. Neil Nandi and rheumatologist Dr. Monica Schwartzman.

Host: Neilanjan Nandi, MD Guest: Samir Shah, MD From new guideline recommendations to a concert featuring the American College of Gastroenterology’s official band, a lot is being done to help raise awareness of the importance of screening for colorectal cancer. So how can you help increase screening rates in your own community? Get inspired with these creative initiatives shared by Dr. Neil Nandi and Dr. Samir Shah, President of the American College of Gastroenterology.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Michelle Hughes, MD Over the past two decades, there has been an increasing need for GI hospitalists to help provide rapid access to care. Since then, GI hospitalists have become an important part to many healthcare systems and their approach to patient care. Joining Dr. Peter Buch to discuss the benefits and challenges that come along with the GI hospitalist role is Dr. Michelle Hughes, Assistant Professor of Medicine and Medical Chief of Quality and Safety at Yale School of Medicine.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Amir E. Masoud, MD Gastroparesis affects approximately five million people in the United States alone, and there are more than 50 recognized causes. In recent years, however, it's been shown that simply accelerating gastric emptying may not improve symptoms, and the overlap of functional dyspepsia and gastroparesis has further clouded our understanding of this condition. So to help clear up some of that confusion, Dr. Peter Buch speaks with Dr. Amir Masoud about treatment strategies for gastroparesis.

Host: Neilanjan Nandi, MD Guest: Karen Krok, MD, FAASLD While hepatologists can help gastroenterologists manage the pulmonary manifestations that may occur in our patients with chronic liver disease, it’s still important for gastroenterologists to know what they should be on the lookout for so that patients can receive timely and appropriate treatment. Additionally, gastroenterologists need to consider the potential impacts of those pulmonary manifestations on transplant outcomes. Joining Dr. Neil Nandi to discuss those and other key considerations gastroenterologists need to know is Dr. Karen Krok from Penn State Health Milton S. Hershey Medical Center.

Host: Neilanjan Nandi, MD Guest: Nitin K. Ahuja, MD The symptoms of early satiety, chronic nausea, and even vomiting can be physically and emotionally challenging for the gastroparesis patient. Adding to the challenge is the fact that the journey from diagnosis to treatment is often daunting and frustrating. So to help us combat these challenges, Dr. Neil Nandi speaks with Dr. Nitin Ahuja, who walks us through the ins and outs of diagnosing and managing gastroparesis.

Host: Neilanjan Nandi, MD Guest: Nicholas Shaheen, MD, MPH How do we determine which of our patients with Barrett's esophagus with dysplasia are good candidates for ablation therapy, and what’s the role of the gastroenterologist in serving patients who've already received post-ablative therapy? Joining Dr. Neil Nandi to answer those and other key questions is Dr. Nicholas Shaheen, who was the primary investigator of one of the largest multicenter studies of radiofrequency ablation.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Donna Cipolla, MD Microscopic colitis can have a variety of symptoms ranging from very mild to debilitating. Fortunately, there are several treatment options and strategies available that can help you alleviate your patient’s symptoms. Joining Dr. Peter Buch to share those options and strategies is Dr. Donna Cipolla.

Host: Neilanjan Nandi, MD Guest: Monica Schwartzman, MD, MS It's currently estimated that 50 percent of IBD patients experience some form of joint stiffness, otherwise known as arthralgia. With so many patients being affected, how can you determine if it’s inflammatory or noninflammatory arthralgia and treat it appropriately? To find out, Dr. Neil Nandi speaks with Dr. Monica Schwartzman, assistant attending physician at the Hospital for Special Surgery and Clinical Instructor of Medicine at Weill Cornell Medical College. Together, they’ll discuss the screening tools gastroenterologists can use to differentiate the types of arthralgia in their patients as well as key management approaches.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Jonathan Leighton, MD If you suspect your patient might have small bowel bleeding despite a massive workup, what evaluation tools are at your disposal to help you find out for sure? Tune in to hear Dr. Peter Buch explore the available tools—and their inherent challenges to be aware of—with Dr. Jonathan Leighton, one of the nation’s leading experts on small bowel bleeding.